Skip to main content
    R

    Rallybio Corp (RLYB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.29
    -0.13 (-0.88%)

    Market Cap: $88.03M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Rallybio Corp (RLYB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Rallybio (RLYB) has a market cap of $88.03M. It kept 6177.42% of revenue as net income over the last 12 months. It holds $90.69M more cash than debt, 103.02% of its market cap.

    Total Valuation

    Market Cap$88.03M
    Latest price (Nov 17, 2026)$15.29

    Key Dates

    Last Earnings DateOct 27, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.28% in the quarter ended Sep 30, 2026 and shrank 64.20% a year over 2 years.

    Shares Outstanding5.72M
    Shares Change (YoY)+1.47%
    Shares Change (QoQ)+0.28%
    Share Count Growth (2Y CAGR)-64.20%

    Valuation Ratios

    Sales and book value multiples are 201.3x and 0.9x. Its year-end P/S ranged from 35.3x to 426.0x from 2023 to 2025.

    P/S Ratio201.3x
    P/B Ratio0.9x
    P/OCF Ratio2.8x

    Valuation history and multiples

    Price Statistics

    The stock is up 453.14% over 52 weeks and trades 48.02% above its 50-day average.

    Beta (1Y)1.07
    52-Week Change+453.14%
    1-Month Change+73.27%
    3-Month Change+66.64%
    6-Month Change+99.64%
    5-Year Change-89.12%
    Total Return (1Y)+943.70%
    Total Return (3Y CAGR)+21.18%
    Total Return (5Y CAGR)-22.75%
    Return vs SPY (1Y)+453.77%
    Max Drawdown (1Y)-31.05%
    Max Drawdown (3Y)-92.33%
    Sharpe Ratio (1Y)1.81
    Correlation with SPY (1Y)0.15
    50-Day Average$10.33
    200-Day Average$7.68
    52-Week Range$3.67 to $17.57
    RSI (14 Days)78.9
    Average Volume (20 Days)34.90K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 28.87x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio28.87x
    Quick Ratio28.87x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 29.05% over the last 12 months, against a 5-year average of -49.11%.

    Return on Equity (ROE)29.05%
    Return on Assets (ROA)28.05%
    ROE (5Y Average)-49.11%
    ROA (5Y Average)-45.30%
    ROIC (5Y Average)-14.03%
    Asset Turnover0.01x

    Taxes

    Income tax took 4.98% of pretax income over the last 12 months.

    Income Tax (TTM)$1.40M
    Effective Tax Rate4.98%

    Scores

    RLYB has an Altman Z-Score of 14.09, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score14.09
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $434.00K over the last 12 months is down 35.61% from the 12 months before.

    Revenue$434.00K
    Revenue Growth (YoY)-35.61%
    Gross Profit$434.00K
    Operating Income-$24.22M
    Pretax Income$28.21M
    Net Income$26.81M
    Reported EPS (TTM)-$4.55

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.57% of the $95.58M in total assets.

    Cash and Equivalents$90.69M
    Total Debt$0
    Net Cash$90.69M
    Net Cash Per Share$15.87
    Working Capital$91.49M
    Shareholder Equity$92.30M
    Book Value Per Share$16.15
    Total Assets$95.58M
    Total Liabilities$3.28M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow$30.99M
    FCF Per Share$5.83

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5580.88%.

    Gross Margin100.00%
    Operating Margin-5580.88%
    Pretax Margin6500.92%
    Net Margin6177.42%

    Growth

    Book Value Per Share Growth (2Y CAGR)-27.56%
    Tangible Book Per Share Growth (2Y CAGR)-27.56%

    Revenue and profit by year

    Dividends and Yields

    RLYB does not pay a dividend.

    Buyback Yield-0.02%
    Shareholder Yield-0.02%

    Stock Splits

    The last split was a 1-for-8 reverse split on Feb 6, 2026.

    Last Split DateFeb 6, 2026
    Split TypeReverse split
    Split Ratio1:8

    Peer Position

    Against 7 similar companies, RLYB has the highest P/S.

    P/S Ratio201.3x vs 16.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)-35.61% vs -42.77% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About RLYB

    What is RLYB's market cap?

    Rallybio has a market cap of $88.03M.

    How many shares of RLYB are outstanding?

    Rallybio has 5.72M shares outstanding. The count is up 1.47% from a year earlier.

    Does RLYB pay a dividend?

    No. Rallybio does not pay a dividend.

    How much debt does RLYB have?

    Rallybio has $0 of total debt and $90.69M of cash and equivalents, a net cash position of $90.69M.